STARS and STARS Extension
Studies to Assess the Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
Studies to Assess the Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS
Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis
A Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Ocrelizumab In Adult Participants With Primary Progressive Multiple Sclerosis
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson’s Disease
Simufilam 100 mg for Mild to Moderate Alzheimer’s Disease
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Hearing Study | FX-322 Can a single dose medication potentially restore lost hearing? We’re working to find out. FX-322 is a new investigational drug that aims to activate and restore cells in the inner ear needed for healthy hearing. There are no costs for you to participate. If it is determined that you qualify for …
A clinical research study is underway for people with focal epilepsy currently taking 1-3 anti-epileptic drugs that are still experiencing frequent seizures. Three doses of investigational drug are being studied and some participants will be assigned placebo. All participants will receive active study on the extension study.
Meniere’s Disease Have you been diagnosed with Meniere’s disease? If so, you may be eligible for a clinical trial. This trial is being conducted to see if the Investigational Product helps with vertigo episodes in patients with Meniere’s disease. Inclusion Criteria Be from 18-85 years of age Have been diagnosed with Meniere’s disease in one …